Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

• Skipping antibiotic doses can lower drug levels and reduce effectiveness. • Missing doses—especially multiple—can slow recovery and raise antibiotic resistance risk. • Don’t double doses; take a ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

Now, before I get into it, I will preface this review by saying my liver was fine to begin with. And if my liver were to give me issues, I would go to a doctor (as you should too!) before ever turning ...

At 69 years old, Debby Orcutt was diagnosed last year with pancreatic cancer, a condition so dire that her doctor refused to tell her how long she had to live. With few good options, she enrolled in a ...

The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical. New Jersey-based ...

President Donald Trump announced a new round of tariffs beginning in October 2025 that would impose a 100% duty on brand name drugs imported to the United States. There's a major exemption to the ...

The U.S. Food and Drug Administration has approved a version of leucovorin made by GlaxoSmithKline, years after the company pulled the drug from consideration when it stopped manufacturing it. The ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

A higher weekly dose of Wegovy achieves even greater weight loss than the standard amount, but this comes with a greater risk of side effects, according to trial results. Prior studies have shown ...

The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks. By Rebecca Robbins Christina Jewett and ...